Literature DB >> 33328352

Suppressor Mutations in Type II Secretion Mutants of Vibrio cholerae: Inactivation of the VesC Protease.

Chelsea S Rule1, Young-Jun Park2, Jaclyn R Delarosa2, Stewart Turley2, Wim G J Hol2, Sarah McColm1, Colby Gura1, Frank DiMaio2, Konstantin V Korotkov2,3, Maria Sandkvist4.   

Abstract

The type II secretion system (T2SS) is a conserved transport pathway responsible for the secretion of a range of virulence factors by many pathogens, including Vibrio cholerae Disruption of the T2SS genes in V. cholerae results in loss of secretion, changes in cell envelope function, and growth defects. While T2SS mutants are viable, high-throughput genomic analyses have listed these genes among essential genes. To investigate whether secondary mutations arise as a consequence of T2SS inactivation, we sequenced the genomes of six V. cholerae T2SS mutants with deletions or insertions in either the epsG, epsL, or epsM genes and identified secondary mutations in all mutants. Two of the six T2SS mutants contain distinct mutations in the gene encoding the T2SS-secreted protease VesC. Other mutations were found in genes coding for V. cholerae cell envelope proteins. Subsequent sequence analysis of the vesC gene in 92 additional T2SS mutant isolates identified another 19 unique mutations including insertions or deletions, sequence duplications, and single-nucleotide changes resulting in amino acid substitutions in the VesC protein. Analysis of VesC variants and the X-ray crystallographic structure of wild-type VesC suggested that all mutations lead to loss of VesC production and/or function. One possible mechanism by which V. cholerae T2SS mutagenesis can be tolerated is through selection of vesC-inactivating mutations, which may, in part, suppress cell envelope damage, establishing permissive conditions for the disruption of the T2SS. Other mutations may have been acquired in genes encoding essential cell envelope proteins to prevent proteolysis by VesC.IMPORTANCE Genome-wide transposon mutagenesis has identified the genes encoding the T2SS in Vibrio cholerae as essential for viability, but the reason for this is unclear. Mutants with deletions or insertions in these genes can be isolated, suggesting that they have acquired secondary mutations that suppress their growth defect. Through whole-genome sequencing and phenotypic analysis of T2SS mutants, we show that one means by which the growth defect can be suppressed is through mutations in the gene encoding the T2SS substrate VesC. VesC homologues are present in other Vibrio species and close relatives, and this may be why inactivation of the T2SS in species such as Vibrio vulnificus, Vibrio sp. strain 60, and Aeromonas hydrophila also results in a pleiotropic effect on their outer membrane assembly and integrity.
Copyright © 2020 Rule et al.

Entities:  

Keywords:  Vibrio cholerae; protein structure; serine protease; suppressor; type II secretion system

Year:  2020        PMID: 33328352      PMCID: PMC7771236          DOI: 10.1128/mSphere.01125-20

Source DB:  PubMed          Journal:  mSphere        ISSN: 2379-5042            Impact factor:   4.389


  67 in total

Review 1.  Type II secretion and pathogenesis.

Authors:  M Sandkvist
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  The Aeromonas hydrophila exeE gene, required both for protein secretion and normal outer membrane biogenesis, is a member of a general secretion pathway.

Authors:  B Jiang; S P Howard
Journal:  Mol Microbiol       Date:  1992-05       Impact factor: 3.501

3.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

Review 4.  Using structure to inform carbohydrate binding module function.

Authors:  D Wade Abbott; Alicia Lammerts van Bueren
Journal:  Curr Opin Struct Biol       Date:  2014-08-09       Impact factor: 6.809

5.  Refinement of protein structures into low-resolution density maps using rosetta.

Authors:  Frank DiMaio; Michael D Tyka; Matthew L Baker; Wah Chiu; David Baker
Journal:  J Mol Biol       Date:  2009-07-08       Impact factor: 5.469

6.  Isolation and analysis of eight exe genes and their involvement in extracellular protein secretion and outer membrane assembly in Aeromonas hydrophila.

Authors:  S P Howard; J Critch; A Bedi
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

7.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

8.  Disruption of Escherichia coli hepA, an RNA polymerase-associated protein, causes UV sensitivity.

Authors:  O Muzzin; E A Campbell; L Xia; E Severinova; S A Darst; K Severinov
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

9.  Role of a TehA homolog in Vibrio cholerae C6706 antibiotic resistance and intestinal colonization.

Authors:  Bin Pei; Yuning Wang; David S Katzianer; Hui Wang; Hui Wu; Zengtao Zhong; Jun Zhu
Journal:  Can J Microbiol       Date:  2013-01-03       Impact factor: 2.419

10.  High-resolution comparative modeling with RosettaCM.

Authors:  Yifan Song; Frank DiMaio; Ray Yu-Ruei Wang; David Kim; Chris Miles; Tj Brunette; James Thompson; David Baker
Journal:  Structure       Date:  2013-09-12       Impact factor: 5.006

View more
  1 in total

1.  NBCZone: Universal three-dimensional construction of eleven amino acids near the catalytic nucleophile and base in the superfamily of (chymo)trypsin-like serine fold proteases.

Authors:  Alexander I Denesyuk; Mark S Johnson; Outi M H Salo-Ahen; Vladimir N Uversky; Konstantin Denessiouk
Journal:  Int J Biol Macromol       Date:  2020-03-06       Impact factor: 8.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.